Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial
about
Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgeryPerioperative beta-blockers for preventing surgery-related mortality and morbidityBeta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgeryLearning from mistakes in clinical practice guidelines: the case of perioperative β-blockadeCoronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation.Evidence at a glance: error matrix approach for overviewing available evidenceA randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study.Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery.2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of AA regional quality improvement effort to increase beta blocker administration before vascular surgery.Genetic variation, β-blockers, and perioperative myocardial infarction.Elevated cardiac troponin in the early post-operative period and mortality following ruptured abdominal aortic aneurysm: a retrospective population-based cohort studyCombined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.Preoperative Cardiac Evaluation and Management of the Patient Undergoing Major Vascular Surgery.Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization.Beta-blockers and risk of all-cause mortality in non-cardiac surgery.Safety of perioperative β-blocker use: how do β-blockers compare in terms of side effects?Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches.Preoperative cardiac evaluation of the vascular surgery patient--an anesthesia perspective.Endovascular aneurysm repair: a perioperative perspective.Cardiac risk assessment before non-cardiac surgery.Patients who require non-cardiac surgery in acute coronary syndrome.Peri-operative cardiac protection for non-cardiac surgery.Beta-blocker subtype and risks of perioperative adverse events following non-cardiac surgery: a nationwide cohort study.Commentary : The value of intraoperative neurophysiological monitoring: evidence, equipoise and outcomes.Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful.β-blockers in critically ill patients: from physiology to clinical evidence.Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice.3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.Perioperative use of beta-blockers.Prognostic studies of perioperative risk: robust methodology is needed.Essay for the CIHR/CMAJ award: impact of the Perioperative Ischemic Evaluation (POISE) trial.Beta blockers and statins in non-cardiac surgery.Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients.Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients.The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study.Back to the future: medical reversals and perioperative medicine.Beta-blockers for non-acute treatment after myocardial infarction
P2860
Q24186611-DA4FF774-82B2-4E44-B2BC-8B51F50BBF77Q24193541-B5B1382B-CBEF-4E24-8167-04B45CE2EE54Q24243256-89C76420-7C19-428A-892E-40D95FA8E4D8Q24289034-13FE2F49-F91A-47A7-92C0-168634600072Q33654004-E6B67415-3ED2-4CAE-A9BE-B11A7C52128CQ33710053-E6336FBD-9B39-4B6C-BC66-C32B8BB861A6Q34324204-1F3BE9BB-AC37-4589-A07A-1D9384FB592FQ34361033-15488B13-40A1-4182-8FEE-8EE453E738DBQ34431980-8EFC70D0-A315-4EDC-BF4B-4294AB49C35DQ34987813-C12E7998-E538-47CC-AB52-C9B13C5EE552Q35580952-0A0B1E8D-C661-4BAF-AE3A-290048F8E675Q36633988-8D1E2615-9CE0-42F0-A6C6-4393400D50A0Q36955252-2B550879-59E8-4A2E-AF31-B402193E071CQ37381635-73AE6F60-B844-4562-803E-ACAEA586F46AQ37472056-788678F1-2E18-4D89-871E-55306793BA4DQ37702033-B96E8C71-FCDE-4692-A27E-AE0C8FE3403FQ37830055-BF581CD3-2656-4DCE-8BFE-5C21121162DAQ37892419-5A4015C1-6431-48D5-A811-94DB4A964806Q37992531-7F499A55-AB1C-4F0F-8522-8C08EAA43009Q38012515-C7AC8EAE-0FF5-479C-8F78-7CE71A753833Q38071617-BCBD2EE2-D9D3-4B79-9428-B0B2D71FAAECQ38107887-DA73E9AB-C17F-4ED5-8DCE-AD890F41F5E6Q38653570-BE3942C8-A340-4258-84A9-65AE10E0B47DQ38687689-E00C403A-80C2-4698-8D46-95DE57B335D5Q38915553-3B25355B-0788-4ED2-BA4F-2F7957057736Q40386821-8A4ABDE1-C853-40AE-8DC8-B7447A0506F4Q40792445-196043DA-E16E-4807-B986-5AB37FC05142Q40945236-78024AC1-227C-4400-B20A-AD8B4F814A95Q42028649-875F03C3-AECB-462A-A940-449CA4C7A698Q42134079-AF79BA86-D812-4E9E-B41D-40E2F0DCC3FAQ42415622-06EB9DE1-2BE4-4A39-BB5A-201CDA06D862Q42532701-29E21EE1-F9D9-41FD-A608-8E6849B1ACC4Q42707836-D6384D03-D707-4992-98F7-D149ADC5B189Q42741918-3CA08A2C-DDCD-4A25-804D-EBD34C01306BQ43284567-31F0FB27-9A0E-437B-BBFF-D8F303706E0FQ44554341-2747CFAF-D655-43B8-945B-1D6374A4448AQ46804046-E5046D32-1B37-4080-A7E2-AA4D74086933Q48216139-AE49674A-A039-4C9F-A64C-B18C19E2F0E3Q49134468-138588C3-0E17-4196-A95B-136573104CB5Q57389407-E73474BF-F79C-4D60-AECB-2706C9AA5733
P2860
Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of perioperative beta b ...... led, blinded multicentre trial
@ast
Effect of perioperative beta b ...... led, blinded multicentre trial
@en
Effect of perioperative beta b ...... led, blinded multicentre trial
@nl
type
label
Effect of perioperative beta b ...... led, blinded multicentre trial
@ast
Effect of perioperative beta b ...... led, blinded multicentre trial
@en
Effect of perioperative beta b ...... led, blinded multicentre trial
@nl
prefLabel
Effect of perioperative beta b ...... led, blinded multicentre trial
@ast
Effect of perioperative beta b ...... led, blinded multicentre trial
@en
Effect of perioperative beta b ...... led, blinded multicentre trial
@nl
P2093
P2860
P50
P921
P1433
P1476
Effect of perioperative beta b ...... led, blinded multicentre trial
@en
P2093
Allan Kofoed-Enevoldsen
André Miran
Anne Benedicte Juul
Anne Munksgaard
Bjarne Øberg
Bjørn Dehlie
Boris Khanykin
DIPOM Trial Group
Dusanka Zaric
Frank Pott
P2860
P356
10.1136/BMJ.332.7556.1482
P407
P577
2006-06-01T00:00:00Z